Aflibercept formulations and uses thereof
US11135266B2 · kind B2 · utility
3Cited by
29References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 20, 2017 |
| Grant date | Oct 5, 2021 |
| Priority date | — |
| Expiry date | Jan 17, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Ophthalmic formulations comprising aflibercept are disclosed that are suitable for a method of treatment of an eye disorder or disease by intravitreal or topical administration.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.